Hoth Therapeutics | 4:持股變動聲明-董事 Pavell Jeff
Hoth Therapeutics | 4:持股變動聲明-董事 Sarnoff David
Hoth Therapeutics | 4:持股變動聲明-高管 Knie Robb
Hoth Therapeutics | 4:持股變動聲明-董事 Linsley Wayne
Hoth Therapeutics | 4:持股變動聲明-高管 Knie Robb
Hoth Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Armistice Capital, LLC(4.99%),Steven Boyd(4.99%)
Hoth Therapeutics | 4:持股變動聲明-董事 Springer Graig
Hoth Therapeutics | 4:持股變動聲明-董事 Sarnoff David
Hoth Therapeutics | 4:持股變動聲明-董事 Pavell Jeff
Hoth Therapeutics | 4:持股變動聲明-董事 Linsley Wayne
Hoth Therapeutics | 4:持股變動聲明-高管 Knie Robb
Hoth Therapeutics | 4:持股變動聲明-董事 Sarnoff David
Hoth Therapeutics | 4:持股變動聲明-董事 Springer Graig
Hoth Therapeutics | 4:持股變動聲明-高管 Knie Robb
Hoth Therapeutics | 4:持股變動聲明-董事 Pavell Jeff
Hoth Therapeutics | 4:持股變動聲明-董事 Linsley Wayne
Hoth Therapeutics | SC 13G:超過5%持股股東披露文件-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)
Hoth Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Mitchell P. Kopin(4.2%),Daniel B. Asher(4.2%)等
Hoth Therapeutics | D:發行公告
Hoth Therapeutics | 4:持股變動聲明